Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
La Nouvelle Presse Medicale
|
December 1, 1978
[Surgery for carcinoma of the oesophagus. A plea for precise technique and pleuro-mediastinal drainage (author's transl)]
L Toty, J Y Roche, P Hertzog, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
January 28, 1982
[Is there any justification to the scintigraphy and echotomography B association for the tracking down of hepatic metastases? (author's transl)]
J C Boucherie, L Morand, J Paillard, et al.
The Journal of Infectious Diseases
|
June 2, 1998
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection
J J Lefrère, F Roudot-Thoraval, M Mariotti, et al.
Presse Medicale (Paris, France : 1983)
|
February 24, 2001
[Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]
J L Meynard, M Guiguet, A Rachline, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons
J J Lefrère, F Roudot-Thoraval, L Morand-Joubert, et al.
AIDS Research and Human Retroviruses
|
January 20, 1996
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions
L Belec, A Jean Georges, M C Hallouin, et al.
Analytical Chemistry
|
July 27, 2001
Increasing bioanalytical throughput using pcSFC-MS/MS: 10 minutes per 96-well plate
S H Hoke, J A Tomlinson, R D Bolden, et al.
Blood
|
August 1, 1997
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection
J J Lefrère, L Morand-Joubert, M Mariotti, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment
A G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Infectious Diseases
|
February 1, 1997
Full or partial seroreversion in patients infected by hepatitis C virus
J J Lefrère, S Guiramand, F Lefrère, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
La Nouvelle Presse Medicale
|
December 1, 1978
[Surgery for carcinoma of the oesophagus. A plea for precise technique and pleuro-mediastinal drainage (author's transl)]
L Toty, J Y Roche, P Hertzog, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
January 28, 1982
[Is there any justification to the scintigraphy and echotomography B association for the tracking down of hepatic metastases? (author's transl)]
J C Boucherie, L Morand, J Paillard, et al.
The Journal of Infectious Diseases
|
June 2, 1998
The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection
J J Lefrère, F Roudot-Thoraval, M Mariotti, et al.
Presse Medicale (Paris, France : 1983)
|
February 24, 2001
[Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]
J L Meynard, M Guiguet, A Rachline, et al.
The Journal of Infectious Diseases
|
March 9, 1999
Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons
J J Lefrère, F Roudot-Thoraval, L Morand-Joubert, et al.
AIDS Research and Human Retroviruses
|
January 20, 1996
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions
L Belec, A Jean Georges, M C Hallouin, et al.
Analytical Chemistry
|
July 27, 2001
Increasing bioanalytical throughput using pcSFC-MS/MS: 10 minutes per 96-well plate
S H Hoke, J A Tomlinson, R D Bolden, et al.
Blood
|
August 1, 1997
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection
J J Lefrère, L Morand-Joubert, M Mariotti, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment
A G Marcelin, B Visseaux, M Wirden, et al.
The Journal of Infectious Diseases
|
February 1, 1997
Full or partial seroreversion in patients infected by hepatitis C virus
J J Lefrère, S Guiramand, F Lefrère, et al.
Page
of 6